Increasing COVID-19 Vaccine Uptake in Developing Countries (Bihar)
20. juni 2022 oppdatert av: Yale University
Working with governments in Bihar, India, we will evaluate a number of mechanisms to increase vaccine uptake.
These include household vaccination visits instead of community vaccination clinic.monetary
and non-monetary incentives, and concurrent mask promotion.
This ClinicalTrials entry contains results only for the study in Bihar.
Studieoversikt
Status
Fullført
Forhold
Detaljert beskrivelse
The goal of the study is to identify strategies that best promote and support COVID vaccine uptake in developing countries, we propose to test a range of scalable social and behavioural interventions. This could help policy makers design and employ interventions that are effective. This is especially valuable in resource constrained contexts where funds and institutional resources can be diverted towards interventions that have proven to work.
In Bihar the intervention will be village-level social mobilization involving community promotion, including in-person vaccine reinforcement, and household-level social mobilization. Some treatment villages will receive household- level interventions with varying intensity (different proportion of households will be visited). There will also an accompanying mask distribution campaign during household visits where the importance of mask-wearing as a complement to vaccine use will be explained.
This ClinicalTrials entry contains results only for the study in Bihar.
Studietype
Intervensjonell
Registrering (Faktiske)
114512
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Bihar
-
Patna, Bihar, India, 800001
- Project Concern International
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
15 år og eldre (Barn, Voksen, Eldre voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Lives in study village
Exclusion Criteria:
- Does not live in study village
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Ingen inngripen: Control
No vaccine or mask promotion, but access to vaccines increased to match access in intervention villages
|
|
|
Eksperimentell: Village-level vaccine clinics with monetary, non-monetary, or no incentive
Village-level vaccine clinics with monetary, non-monetary, or no incentive.
Villages are cross-randomized to grocery coupon, food ration, no incentive, or grocery coupon to both community member and community health worker after the community member has received a vaccination.
|
Individuals will be provided with a guaranteed cash payment, entry into a cash lottery, or guaranteed gift of food if they are vaccinated
Vaccines are conducted at the household-level rather than the village-level
Village-level social mobilization campaign to be vaccinated
|
|
Eksperimentell: Household-level vaccination with monetary or no incentive
Household-level vaccination with monetary incentive or no incentive.
Villages are cross-randomized to grocery coupon or no incentive upon receiving vaccination
|
Individuals will be provided with a guaranteed cash payment, entry into a cash lottery, or guaranteed gift of food if they are vaccinated
Vaccines are conducted at the household-level rather than the village-level
Village-level social mobilization campaign to be vaccinated
|
|
Eksperimentell: Village-level vaccination without incentive, plus mask promotion
Individuals are encourage to attend village-level vaccine clinics but not given any incentive.
Mask distribution and reinforcement activities are conducted in villages at a similar time as vaccine promotion.
|
Vaccines are conducted at the household-level rather than the village-level
Village-level social mobilization campaign to be vaccinated
Individuals are given cloth masks
Individuals who are not wearing masks over their mouth and nose are stopped in public places and encouraged to wear a mask
|
|
Eksperimentell: Village-level vaccination without incentive
Individuals are encourage to attend village-level vaccine clinics but not given any incentive.
|
Vaccines are conducted at the household-level rather than the village-level
Village-level social mobilization campaign to be vaccinated
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Percent of individuals who receive the first, second, or third dose of covid vaccine
Tidsramme: up to 4 weeks (endline may vary depending on estimated uptake rates)
|
Prevalence of vaccination with difference doses
|
up to 4 weeks (endline may vary depending on estimated uptake rates)
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
19. januar 2022
Primær fullføring (Faktiske)
27. april 2022
Studiet fullført (Faktiske)
27. april 2022
Datoer for studieregistrering
Først innsendt
2. februar 2022
Først innsendt som oppfylte QC-kriteriene
2. februar 2022
Først lagt ut (Faktiske)
4. februar 2022
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
22. juni 2022
Siste oppdatering sendt inn som oppfylte QC-kriteriene
20. juni 2022
Sist bekreftet
1. juni 2022
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2000031541
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Incentives to be vaccinated
-
Gérard AmarencoFullførtMultippel sklerose | Gangforstyrrelser, nevrologisk | Urininkontinens, UrgeFrankrike
-
University of Alabama at BirminghamNational Cancer Institute (NCI)RekrutteringKreft | FamiliemedlemmerForente stater
-
University of Alabama at BirminghamFullførtKreft | Familie omsorgspersonerForente stater
-
Children's Hospital of PhiladelphiaUniversity of Pennsylvania; National Center for Advancing Translational...AvsluttetRøykesluttForente stater
-
Marmara UniversityRekrutteringKoronar bypass-graftkirurgiTyrkia